All patients with type 1 diabetes in England should be offered continuous glucose monitoring, says NICE
BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o834 (Published 31 March 2022) Cite this as: BMJ 2022;376:o834
- Gareth Iacobucci
- The BMJ
Everyone with type 1 diabetes in England should be offered some form of continuous glucose monitoring (CGM) technology to support their care, the National Institute for Health and Care Excellence has recommended.1
Updated guidelines published on 31 March recommend that all adults with type 1 diabetes should be offered a choice of either real time or intermittent (flash) CGM through a sensor attached to the skin as part of their ongoing NHS care.
NICE also recommends2 that all young people aged 4 years and over with type 1 diabetes should be offered real time CGM in the first instance or a …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.